Heshi Eye Hospital and Johnson & Johnson Vision Strengthen Strategic Collaboration to Build an Innovative Ophthalmic Health Ecosystem

AI ExpressOn September 6, during the 29th Chinese Medical Association Ophthalmology Academic Conference (CCOS2025),He EyeDeepening Strategic Cooperation with Johnson & Johnson's Eye Health Business, Johnson & Johnson Vision. The two parties signed the 2025 Strategic Cooperation Agreement and inaugurated the "Presbyopia Diagnosis and Treatment Center Strategic Cooperation Group" and the "Refractive Cataract Global Innovation Technology Strategic Cooperation Group," aiming to create a full-chain platform for precision refractive diagnosis and treatment.

"Global Innovation Technology Strategic Cooperation Group for Refractive Cataract" will focus on the clinical value verification and application of cutting-edge technologies and innovative products worldwide. With the seventh-generation "Catalys Whitestar" intelligent femtosecond laser system as its technological core, the group ensures precise implantation of functional intraocular lenses.

The "Presbyopia Diagnosis and Treatment Center Strategic Cooperation Group" will integrate the advanced technology of He Eye's Refractive Cataract Center to jointly explore personalized presbyopia solutions. By consolidating the advantageous resources of both parties, the collaboration aims to drive innovation and upgrading in presbyopia diagnosis and treatment technologies, thereby providing patients with higher quality and more efficient medical services.

(AI-generated article, for reference only)